Drug Fever Due to Favipiravir Administration for the Treatment of a COVID-19 Patient

A 55-year-old Japanese man was hospitalized with the novel coronavirus disease 2019 (COVID-19). On the 14th day after the start of favipiravir administration, the patient developed a fever with a temperature of 38.1℃. His pulse rate also became elevated to 128 bpm, so relative bradycardia was not su...

Descripción completa

Detalles Bibliográficos
Autores principales: Tawara, Junsuke, Uehara, Takanori, Sakao, Seiichiro, Igari, Hidetoshi, Taniguchi, Toshibumi, Kasai, Hajime, Takayanagi, Shin, Yahaba, Misuzu, Shimada, Ryo, Ikusaka, Masatomi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079902/
https://www.ncbi.nlm.nih.gov/pubmed/33583886
http://dx.doi.org/10.2169/internalmedicine.5813-20
Descripción
Sumario:A 55-year-old Japanese man was hospitalized with the novel coronavirus disease 2019 (COVID-19). On the 14th day after the start of favipiravir administration, the patient developed a fever with a temperature of 38.1℃. His pulse rate also became elevated to 128 bpm, so relative bradycardia was not suspected. Since he was in good overall health and no concomitant symptoms and signs were apparent, we considered it to be drug fever due to favipiravir. After the completion of favipiravir treatment, the patient's temperature normalized within 24 hours. We herein report this case of drug fever caused by favipiravir.

Ejemplares similares